Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024? скачать в хорошем качестве

Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024?

This ERN ReCONNET webinar brings together 2 European experts familiar with the subject of Pulmonary Arterial Hypertension (PAH) and systemic sclerosis, Prof. Eric Hachulla and Prof. Olivier Sitbon. Professor Eric Hachulla provides an update on PAH's current classification and definition and a critical analysis of the various screening methods (benefits and limitations) based on international recommendations. Professor Olivier Sitbon discusses the various current and future therapeutic strategies. Speakers of this webinar are: 1) Prof. Eric Hachulla (MD, PhD, Lille University Hospital, France) 2) Prof. Olivier Sitbon (MD, PhD, Hôpital Bicêtre in Le Kremlin - Bicêtre, France) The moderator of this webinar is Prof. Vanessa Smith (MD, Ghent University Hospital - UZ Gent, Belgium) Eric Hachulla, MD, PhD, is Professor of Internal Medicine at Lille University Hospital. He is the coordinator of a referral Centre for rare auto-immune diseases. He has published numerous works, mainly on CDT, and coordinates several Inter-University Diplomas and European courses available online. Since February 2014, he has been coordinating the FAI2R health network for rare autoimmune and auto-inflammatory diseases. Olivier Sitbon, MD, PhD, is Professor of Respiratory Medicine at Université Paris-Saclay and a consultant at the French Referral Center for Pulmonary Hypertension (PH), Department of Respiratory and Intensive Care Medicine, Hôpital Bicêtre in Le Kremlin-Bicêtre, France. He is a fellow of the European Respiratory Society (ERS) and the current secretary of the ERS Assembly 13 on Pulmonary Vascular Diseases. Professor Sitbon has conducted extensive research in pulmonary arterial hypertension (PAH) and he is the scientific leader and coordinator of the French PH Registry. His investigational activities include clinical studies on factors associated with PAH, identification of prognostic factors, studies on risk stratification and treatment goals, and the development of new strategies for the treatment of PAH. He was a task force member and section editor of the 2022 ESC-ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. He has authored more than 410 peer-reviewed articles on PH and related topics in high-ranking scientific journals. More info about SSc can be found here: https://reconnet.ern-net.eu/disease-ssc/ You can register to the ERN ReCONNET Newsletter at the following link: https://reconnet.ern-net.eu/subscribe...